Agentschap Innoveren & Ondernemen logo

Agentschap Innoveren & Ondernemen

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels

Description

Agentschap Innoveren & Ondernemen (VLAIO) is the primary government agency in Flanders, Belgium, tasked with implementing the region's economic, innovation, and enterprise policy. Unlike traditional venture capital firms, VLAIO does not engage in equity investments but rather provides a comprehensive suite of non-dilutive financial support, advice, and networking opportunities to stimulate business growth, innovation, and internationalization within the Flemish ecosystem. Its core mission revolves around fostering a dynamic and competitive business environment for both established companies and emerging startups.

VLAIO's financial instruments primarily consist of grants, subsidies, and guarantees tailored to various stages of a company's lifecycle and specific project types. For instance, it offers significant support for research and development (R&D) projects, where companies can receive subsidies covering 25% to 50% of eligible project costs. Other notable programs include growth subsidies aimed at accelerating the expansion of promising businesses, and innovation mandates designed to support the hiring of specialized research personnel. These diverse offerings underscore VLAIO's commitment to de-risking innovation and enabling strategic investments for Flemish enterprises.

The typical "first cheque" from VLAIO, understood as an initial substantial grant for an innovation or growth project, can vary widely depending on the program and project scope. For many innovation-driven SMEs, initial project subsidies often range from approximately €50,000 ($54,000 USD) for smaller development initiatives to around €500,000 ($540,000 USD) for larger, more ambitious R&D or strategic transformation projects. While smaller subsidies like the KMO Portefeuille exist for training and advice, these larger project grants represent the agency's more significant direct financial contributions to a company's strategic objectives. VLAIO's support is crucial for companies seeking to innovate and scale without diluting their ownership.

Investor Profile

Agentschap Innoveren & Ondernemen has backed more than 54 startups, with 2 new investments in the last 12 months alone. The firm has led 42 rounds, about 78% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Pre Seed, Debt Financing rounds (top funding stages).
  • Majority of deals are located in Belgium, Israel, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 2 rounds in the past year.
  • Typical check size: $54K – $540K.

Stage Focus

  • Grant (81%)
  • Pre Seed (9%)
  • Debt Financing (4%)
  • Series A (2%)
  • Angel (2%)
  • Seed (2%)

Country Focus

  • Belgium (93%)
  • Israel (2%)
  • Germany (2%)
  • Switzerland (2%)
  • Italy (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Software
  • Waste Management
  • Information Technology
  • Agriculture
  • Cleantech
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Agentschap Innoveren & Ondernemen frequently co-invest with?

The Birdhouse
Europe, Oost-Vlaanderen, Belgium, Ghent
Co-Investments: 1
Techstars
North America, Colorado, United States, Boulder
Co-Investments: 1
Fashion For Good
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Beringea
North America, Michigan, United States, Farmington Hills
Co-Investments: 1
imec.istart
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 2
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
HF
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 3

Which angels does Agentschap Innoveren & Ondernemen often collaborate with?

NA
Europe, Oost-Vlaanderen, Belgium, Gent
Shared Deals: 1

What are some of recent deals done by Agentschap Innoveren & Ondernemen?

Protealis

Gent, Oost-Vlaanderen, Belgium

Sustainable plant proteins for Europe​

AgricultureAgTechBiotechnology
GrantNov 6, 2024
Amount Raised: $1,287,776
Exalate

Antwerpen, Antwerpen, Belgium

With Exalate, achieve seamless integration for any complexity. Whether for basic or advanced configurations, Exalate has you covered.

Information TechnologySoftware
GrantSep 10, 2024
Amount Raised: $201,345
Confo Therapeutics

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

BiotechnologyHealth CareMedicalTherapeutics
GrantMar 28, 2024
Amount Raised: $1,726,568
MICLEDI Microdisplays

Leuven, Vlaams-Brabant, Belgium

MICLEDI Microdisplays is an experienced executive in the semiconductor industry,

Semiconductor
GrantMar 12, 2024
AstriVax

Heverlee, Vlaams-Brabant, Belgium

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

Clinical TrialsMedical
GrantDec 12, 2023
Amount Raised: $3,239,548
ExeVir Bio

Zwijnaarde, Oost-Vlaanderen, Belgium

ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.

BiotechnologyHealth CareLife ScienceTherapeutics
GrantJun 28, 2023
Amount Raised: $1,746,441
Flamingo Therapeutics

Leuven, Vlaams-Brabant, Belgium

Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.

BiopharmaBiotechnologyOncology
GrantJun 15, 2023
Amount Raised: $1,860,726
Stellar Labs

Antwerp, Antwerpen, Belgium

EdTech. Learning transfer, sorted. We help L&D build business-critical skills across organisations, not just share knowledge.

Corporate TrainingE-LearningEdTechEducation
AngelJun 1, 2023
Amount Raised: $1,452,691
AstriVax

Heverlee, Vlaams-Brabant, Belgium

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

Clinical TrialsMedical
GrantMay 30, 2023
Amount Raised: $2,682,901
wehave

Antwerpen, Antwerpen, Belgium

Europe's leading data clean room for customer data. Building audience ecosystems.

Big DataData CenterData IntegrationPersonalization
Pre SeedApr 9, 2023
Amount Raised: $200,000